Published in Hepatitis Weekly, May 26th, 2008
"It has recently been reported that Syk, a non-receptor protein tyrosine kinase, functions as a potent tumor suppressor in human breast carcinoma. This study first examined the possible effect of HCV infection on expression of Syk in vivo....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.